Travel Medicine and Infectious Disease

Papers
(The H4-Index of Travel Medicine and Infectious Disease is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France166
Editorial Board153
Misleading eosinophil counts in migration-associated malaria: do not miss hidden helminthic co-infections137
Authors' response comments on “Diagnosis of monkeypox virus – An overview”124
Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet's disease90
The arrival of Mpox in Venezuela: Why so few cases?83
Murine typhus in returned travelers to Toronto, Canada78
Prevalence of undiagnosed HIV in Venezuelan patients with suspected COVID-19 during the first wave: A complex syndemic77
For how long can monkeypox reach the Balkan region?75
Comment on “Clinical manifestation of Rickettsia rickettsii in a familiar outbreak in Panama”73
Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine68
Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China63
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives58
Malaria risk perceptions and barriers for effective prophylaxis among sub-Saharan African 'visiting friends and relatives' travellers in Hamburg, Germany58
The Honduran diaspora and infectious diseases: An urgent need for action55
Awareness and perceptions of medical students and doctors regarding Tropical Medicine education and training in Europe: An international, online-based survey53
Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis53
Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 202250
Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review49
Airborne infection risk of nearby passengers in a cabin environment and implications for infection control48
Rabies post-exposure prophylaxis in the emergency department: A monocentric retrospective observational study48
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf48
Evidence of autochthonous transmission of urinary schistosomiasis in Almeria (southeast Spain): An outbreak analysis45
Chikungunya and arthritis: An overview45
Leukemoid-like eosinophilia in a splenectomised traveler returning from Brazil43
A case of imported Plasmodium malariae infection after treated Plasmodium falciparum malaria: Possible explanations and a review of the literature42
Global spread of mpox Clade I: Implications for travel and public health40
Is Omicron the end of pandemic or start of a new innings?39
Appropriate vaccinal policies face to asymptomatic monkeypox virus transmission38
Pregnancy-associated malaria: Effects of cytokine and chemokine expression38
Editorial Board37
First imported Clade 1b Mpox case in India: Implications for travel medicine and public health surveillance37
Modeling approaches to inform travel-related policies for COVID-19 containment: A scoping review and future directions37
Types and outcomes of pharmacist-managed travel health services: A systematic review35
0.17134690284729